| Autor: |
Denengelse, L., Dehollander, A.E.M., Dreefvandermeulen, H.C., Feron, V.J., Mohn, G.R., Mulder, G.J., Noordam, P.C., Roelfzema, H., Swaen, G.M.H., Verbeek, A.L.M., Verschuuren, H.G., Vogel, E.W., Vanzorge, J.A., Vanvliet, P.W. |
| Zdroj: |
Regulatory Toxicology and Pharmacology; February 1994, Vol. 19 Issue: 1 p14-30, 17p |
| Abstrakt: |
The Health Council of The Netherlands advises the Dutch government on scientific issues concerning health and environmental protection. In 1978 a committee of the Council established mechanistic criteria for quantitative risk assessment of carcinogenic substances. For this purpose it adopted the multistage model of carcinogenesis. Based on this model two categories of carcinogens were distinguished. The first category includes complete carcinogens and tumor initiators: these agents induce irreversible modification of DNA and act by a stochastic mechanism. The second category includes promotors and other substances acting as cocarcinogens; these agents act by nonstochastic mechanisms. Stochastic action implies that there is no threshold for the contribution to the carcinogenic effect, whereas nonstochastic action implies a threshold dose. Recently, reevaluation of the method for carcinogenic risk assessment was considered due because of remarkable scientific progress since 1978, such as the identification of cellular oncogenes and tumor suppressor genes, and the partial clarification of mechanisms at the cellular and/or molecular level by which tumor promotors stimulate tumor development. The present paper discusses the Dutch method for carcinogenic risk assessment in the light of the recent scientific developments. It concludes that this method for risk assessment is still a valid and appropriate one.Copyright 1994, 1999 Academic Press |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
